| Application no. and date | 15733563.9 (espacenet) (Federated) (European Patent Register), 20150508 | | Patent/reg. no. and date | DK/EP 3142690, 20220223 | | Publication date | 20170322 | | Priority no. and date | US 201461992788 P, 20140513 | | EP pub. no. and date |
EP 3142690 20170322 | | Effective date | | | Applicant/owner | BAVARIAN NORDIC A/S, Philip Heymans Alle 3, 2900 Hellerup, DK | | Applicant ref. no. | 1617313 | | Inventor | ROUNTREE, Ryan, 4029 Briarglen Drive
San Jose, CA 95118, US,
FOY, Susan, 504 Franklin Street
Mountain View, CA 94041, US,
MANDL, Stefanie, 1384 34th Avenue
San Francisco, CA 94122, US,
FRANZUSOFF, Alex, 336 Carmel Ave apt 192,
El Granada, CA 94018, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/39 (2006.01) | | Title | KOMBINATIONSTERAPI TIL BEHANDLING AF CANCER MED ET REKOMBINANT POXVIRUS, DER EKSPRIMERER ET TUMORANTIGEN, OG EN IMMUN-CHECKPOINTMOLEKYLEANTAGONIST ELLER -AGONIST | | Int. application no. | US2015029855 | | Int. publication no. | WO2015175334 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
